Neurent Medical

Healthtech · Galway, IE

Neuromark radiofrequency medical device for the treatment of chronic rhinitis.

Founders

Brian Shields (Ireland · ♂) — Through NUI Galway's BioInnovate medtech-innovation program he identified the unmet need in chronic rhinitis and co-founded Neurent Medical as CEO to develop a radiofrequency nasal-nerve device.
David Townley (Ireland · ♂) — He met Brian Shields through NUI Galway's BioInnovate program and co-founded Neurent Medical as CTO, designing its ENT device for treating chronic runny nose.

Shares the most investors with (number = shared investors):

Date	Round	Amount
Feb 2026	Series C An oversubscribed 62.5 million euro Series C for Neurent Medical led by MVM Partners with Sofinnova Partners, EQT Life Sciences, Atlantic Bridge, Fountain Healthcare and Enterprise Ireland.	$72.5M
Jan 2021	Series B Galway medtech Neurent Medical raised a $25m Series B led by LSP, with Atlantic Bridge and Fountain Healthcare Partners, to fund US expansion.	$25M

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.